Asymptomatic leishmania infection: A new challenge for leishmania control

Clinical Infectious Diseases

Volumn 58, Issue 10, 2014, Pages 1424-1429

  Singh, Om Prakash ^a   Hasker, Epco ^b   Sacks, David ^c   Boelaert, Marleen ^b   Sundar, Shyam ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Asymptomatic infection; Immunity.; Visceral leishmaniasis

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 5; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PARASITE ANTIBODY; PARASITE ANTIGEN;

AGE; ANTIBODY DETECTION; ANTIBODY TITER; ASYMPTOMATIC INFECTION; BED NET; CATTLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD NUTRITION; COW; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOMESTIC ANIMAL; EPIDEMIC; FAMILY HISTORY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEALTH PROGRAM; HELP SEEKING BEHAVIOR; HOUSING; HUMAN; INFECTION CONTROL; INFECTION RESISTANCE; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERFERON PRODUCTION; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; MACROPHAGE; MALNUTRITION; NONHUMAN; NUTRITIONAL STATUS; PARASITE IMMUNITY; PARASITE TRANSMISSION; PERIPHERAL BLOOD MONONUCLEAR CELL; POVERTY; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROPREVALENCE; SOCIAL STATUS; TH17 CELL; VECTOR CONTROL; VISCERAL LEISHMANIASIS; XENODIAGNOSIS; ASYMPTOMATIC INFECTIONS; HETEROZYGOTE; IMMUNOLOGY; LEISHMANIASIS; LEISHMANIASIS, VISCERAL; PARASITOLOGY; RISK FACTOR;

ASYMPTOMATIC INFECTIONS; CARRIER STATE; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS; LEISHMANIASIS, VISCERAL; RISK FACTORS;

EID: 84899837120     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu102     Document Type: Review

References (62)

1. Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and globalestimates of its incidence. PLoS One 2012; 7:e35671.
2. World Health Organization. Eliminating visceral leishmaniasis: a multiprongedapproach. Available at: http://www.who.int/tdr/news/2011/ vlelimination/en/. Accessed 4 November 2011.
3. Badaro R, Jones TC, Carvalho EM, et al. New perspectives on a subclinicalform of visceral leishmaniasis. J Infect Dis 1986; 154:1003-11.
4. Hasker E, Kansal S, Malaviya P, et al. Latent infection with Leishmaniadonovani in highly endemic villages in Bihar, India. PLoS Negl Trop Dis2013; 7:e2053.
5. Srivastava P, Gidwani K, Picado A, et al. Molecular and serological markersof Leishmania donovani infection in healthy individuals fromendemicareas of Bihar, India. Trop Med Int Health 2013; 18:548-54.
6. Stauch A, Sarkar RR, Picado A, et al. Visceral leishmaniasis in the Indiansubcontinent: modelling epidemiology and control. PLoS NeglTrop Dis 2011; 5:e1405.
7. Zijlstra EE, el-Hassan AM, Ismael A, Ghalib HW. Endemic kala-azar ineastern Sudan: a longitudinal study on the incidence of clinical and subclinicalinfection and post-kala-azar dermal leishmaniasis. Am J TropMed Hyg 1994; 51:826-36.
8. Schaefer KU, Kurtzhals JA, Gachihi GS, Muller AS, Kager PA. A prospectivesero-epidemiological study of visceral leishmaniasis in Baringo District,Rift Valley Province, Kenya. Trans R Soc Trop Med Hyg 1995; 89:471-5.
9. Ali A, Ashford RW. Visceral leishmaniasis in Ethiopia. IV. Prevalence,incidence and relation of infection to disease in an endemic area. AnnTrop Med Parasitol 1994; 88:289-93.
10. Evans TG, Teixeira MJ, McAuliffe IT, et al. Epidemiology of visceralleishmaniasis in northeast Brazil. J Infect Dis 1992; 166:1124-32.
11. Moral L, Rubio EM, Moya M. A leishmanin skin test survey in thehuman population of l'Alacanti region (Spain): implications for the epidemiologyof Leishmania infantum infection in southern Europe.Trans R Soc Trop Med Hyg 2002; 96:129-32.
12. Bern C, Haque R, Chowdhury R, et al. The epidemiology of visceralleishmaniasis and asymptomatic leishmanial infection in a highly endemicBangladeshi village. Am J Trop Med Hyg 2007; 76:909-14.
13. Ostyn B, Gidwani K, Khanal B, et al. Incidence of symptomatic andasymptomatic Leishmania donovani infections in high-endemic foci inIndia and Nepal: a prospective study. PLoS Negl Trop Dis 2011; 5:e1284.
14. Topno RK, Das VN, Ranjan A, et al. Asymptomatic infection with visceralleishmaniasis in a disease-endemic area in Bihar, India. Am J TropMed Hyg 2010; 83:502-6.
15. Gumy A, Louis JA, Launois P. The murine model of infection withLeishmania major and its importance for the deciphering of mechanismsunderlying differences in Th cell differentiation in mice from differentgenetic backgrounds. Int J Parasitol 2004; 34:433-44.
16. Robledo S, Wozencraft A, Valencia AZ, Saravia N. Human monocyteinfection by Leishmania (Viannia) panamensis. Role of complement receptorsand correlation of susceptibility in vitro with clinical phenotype.J Immunol 1994; 152:1265-76.
17. Bosque F, Milon G, Valderrama L, Saravia NG. Permissiveness ofhuman monocytes and monocyte-derived macrophages to infectionby promastigotes of Leishmania (Viannia) panamensis. J Parasitol1998; 84:1250-6.
18. Bosque F, Saravia NG, Valderrama L, Milon G. Distinct innate andacquired immune responses to Leishmania in putative susceptible andresistant human populations endemically exposed to L. (Viannia) panamensisinfection. Scand J Immunol 2000; 51:533-41.
19. Carvalho EM, Barral A, Pedral-Sampaio D, et al. Immunologic markersof clinical evolution in children recently infected with Leishmania donovanichagasi. J Infect Dis 1992; 165:535-40.
20. Singh OP, Gidwani K, Kumar R, et al. Reassessment of immune correlatesin human visceral leishmaniasis as defined by cytokine release inwhole blood. Clin Vaccine Immunol 2012; 19:961-6.
21. Hailu A, van Baarle D, Knol GJ, Berhe N, Miedema F, Kager PA. T cellsubset and cytokine profiles in human visceral leishmaniasis during activeand asymptomatic or sub-clinical infection with Leishmania donovani.Clin Immunol 2005; 117:182-91.
22. Mary C, Auriault V, Faugere B, Dessein AJ. Control of Leishmania infantuminfection is associated with CD8(+) and gamma interferon-andinterleukin- 5-producing CD4(+) antigen-specific T cells. Infect Immun1999; 67:5559-66.
23. Pitta MG, Romano A, Cabantous S, et al. IL-17 and IL-22 are associatedwith protection against human kala azar caused by Leishmania donovani.J Clin Invest 2009; 119:2379-87.
24. Gidwani K, Kumar R, Rai M, Sundar S. Longitudinal seroepidemiologicstudy of visceral leishmaniasis in hyperendemic regions of Bihar, India.Am J Trop Med Hyg 2009; 80:345-6.
25. Blackwell JM, Fakiola M, Ibrahim ME, et al. Genetics and visceral leishmaniasis:of mice and man. Parasite Immunol 2009; 31:254-66.
26. Fakiola M, Strange A, Cordell HJ, et al. Common variants in the HLADRB1-HLA-DQA1 HLA class II region are associated with susceptibilityto visceral leishmaniasis. Nat Genet 2013; 45:208-13.
27. Bucheton B, Abel L, Kheir MM, et al. Genetic control of visceral leishmaniasisin a Sudanese population: candidate gene testing indicates alinkage to the NRAMP1 region. Genes Immun 2003; 4:104-9.
28. Mohamed HS, Ibrahim ME, Miller EN, et al. SLC11A1 (formerlyNRAMP1) and susceptibility to visceral leishmaniasis in the Sudan.Eur J Hum Genet 2004; 12:66-74.
29. Mehrotra S, Oommen J, Mishra A, et al. No evidence for associationbetween SLC11A1 and visceral leishmaniasis in India. BMC MedGenet 2011; 12:71.
30. Cerf BJ, Jones TC, Badaro R, Sampaio D, Teixeira R, Johnson WD Jr.Malnutrition as a risk factor for severe visceral leishmaniasis. J InfectDis 1987; 156:1030-3.
31. Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, Melby PC.Malnutrition alters the innate immune response and increases early visceralizationfollowing Leishmania donovani infection. Infect Immun2001; 69:4709-18.
32. Malafaia G, Serafim TD, Silva ME, Pedrosa ML, Rezende SA. Proteinenergymalnutrition decreases immune response to Leishmania chagasivaccine in BALB/c mice. Parasite Immunol 2009; 31:41-9.
33. Harrison LH, Naidu TG, Drew JS, de Alencar JE, Pearson RD. Reciprocalrelationships between undernutrition and the parasitic disease visceralleishmaniasis. Rev Infect Dis 1986; 8:447-53.
34. Hughes S, Kelly P. Interactions of malnutrition and immune impairment,with specific reference to immunity against parasites. ParasiteImmunol 2006; 28:577-88.
35. Mary C, Lamouroux D, Dunan S, Quilici M. Western blot analysis ofantibodies to Leishmania infantum antigens: potential of the 14-kDand 16-kD antigens for diagnosis and epidemiologic purposes. Am JTrop Med Hyg 1992; 47:764-71.
36. Sakru N, Ozensoy Toz S, Korkmaz M, Kavakli T, Alkan MZ, Ozbel Y.The infection risk of visceral leishmaniasis among household membersof active patients. Parasitol Int 2006; 55:131-3.
37. Saghrouni F, Khammari I, Kaabia N, et al. Asymptomatic carriage ofLeishmania in family members of patients with visceral leishmaniasisin central Tunisia. Pathol Biol (Paris) 2011; 60:e55-8.
38. Moura GS, Santos AM, Aquino DM, Silva AA, Caldas Ade J. Factorsassociated with asymptomatic infection in family members and neighborsof patients with visceral leishmaniasis. Cad Saude Publica 2012;28:2306-14.
39. Ranjan A, Sur D, Singh VP, et al. Risk factors for Indian kala-azar. Am JTrop Med Hyg 2005; 73:74-8.
40. Custodio E, Gadisa E, Sordo L, et al. Factors associated with Leishmaniaasymptomatic infection: results from a cross-sectional survey in highlandnorthern Ethiopia. PLoS Negl Trop Dis 2012; 6:e1813.
41. Bern C, Hightower AW, Chowdhury R, et al. Risk factors for kala-azarin Bangladesh. Emerg Infect Dis 2005; 11:655-62.
42. Bern C, Joshi AB, Jha SN, et al. Factors associated with visceral leishmaniasisin Nepal: bed-net use is strongly protective. Am J Trop MedHyg 2000; 63:184-8.
43. Rukunuzzaman M, Rahman M. Epidemiological study of risk factorsrelated to childhood visceral leishmaniasis. Mymensingh Med J 2008;17:46-50.
44. Hasker E, Singh SP, Malaviya P, et al. Visceral leishmaniasis in ruralBihar, India. Emerg Infect Dis 2012; 18:1662-4.
45. Singh SP, Hasker E, Picado A, et al. Risk factors for visceral leishmaniasisin India: further evidence on the role of domestic animals. TropMed Int Health 2010; 15(suppl 2):29-35.
46. Boelaert M, Meheus F, Sanchez A, et al. The poorest of the poor: a povertyappraisal of households affected by visceral leishmaniasis in Bihar,India. Trop Med Int Health 2009; 14:639-44.
47. Barnett PG, Singh SP, Bern C, Hightower AW, Sundar S. Virgin soil: thespread of visceral leishmaniasis into Uttar Pradesh, India. Am J TropMed Hyg 2005; 73:720-5.
48. Picado A, Singh SP, Rijal S, et al. Longlasting insecticidal nets for preventionof Leishmania donovani infection in India and Nepal: pairedcluster randomised trial. BMJ 2010; 341:c6760.
49. Mondal D, Huda MM, Karmoker MK, et al. Reducing visceral leishmaniasisby insecticide impregnation of bed-nets, Bangladesh. EmergInfect Dis 2013; 19:1131-4.
50. Bucheton B, Kheir MM, El-Safi SH, et al. The interplay between environmentaland host factors during an outbreak of visceral leishmaniasisin eastern Sudan. Microbes Infect 2002; 4:1449-57.
51. Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. ClinDiagn Lab Immunol 2002; 9:951-8.
52. Sundar S, Singh RK, Maurya R, et al. Serological diagnosis of Indian visceralleishmaniasis: direct agglutination test versus rK39 strip test. TransR Soc Trop Med Hyg 2006; 100:533-7.
53. Hasker E, Malaviya P, Gidwani K, et al. Strong association between serologicalstatus and probability of progression to clinical visceral leishmaniasisin prospective cohort studies in India and Nepal. PLoS NeglTrop Dis 2014; 8:e2657. doi:10.1371/journal.pntd.0002657.
54. Moreno EC, Goncalves AV, Chaves AV, et al. Inaccuracy of enzymelinkedimmunosorbent assay using soluble and recombinant antigensto detect asymptomatic infection by Leishmania infantum. PLoS NeglTrop Dis 2009; 3:e536.
55. Srivastava P, Dayama A, Mehrotra S, Sundar S. Diagnosis of visceralleishmaniasis. Trans R Soc Trop Med Hyg 2010; 105:1-6.
56. Prina E, Roux E, Mattei D, Milon G. Leishmania DNA is rapidly degradedfollowing parasite death: an analysis by microscopy and realtimePCR. Microbes Infect 2007; 9:1307-15.
57. Bhattarai NR, Van der Auwera G, Khanal B, et al. PCR and direct agglutinationas Leishmania infection markers among healthy Nepalesesubjects living in areas endemic for Kala-Azar. Trop Med Int Health2009; 14:404-11.
58. Gidwani K, Rai M, Chakravarty J, Boelaert M, Sundar S. Evaluation ofleishmanin skin test in Indian visceral leishmaniasis. Am J Trop MedHyg 2009; 80:566-7.
59. Singh OP, Stober CB, Singh AK, Blackwell JM, Sundar S. Cytokine responsesto novel antigens in an Indian population living in an area endemicfor visceral leishmaniasis. PLoS Negl Trop Dis 2012; 6:e1874.
60. Singh OP, Sundar S. Whole blood assay and visceral leishmaniasis: challengesand promises. Immunobiology 2014 [epub ahead of print].doi:10.1016/j. imbio.2014. 01.005.
61. Molina R, Canavate C, Cercenado E, Laguna F, Lopez-Velez R, Alvar J.Indirect xenodiagnosis of visceral leishmaniasis in 10 HIVinfectedpatients using colonized Phlebotomus perniciosus. AIDS1994; 8:277-9.
62. Clements MF, Gidwani K, Kumar R, et al. Measurement of recent exposureto Phlebotomus argentipes, the vector of Indian visceral leishmaniasis,by using human antibody responses to sand fly saliva. Am J TropMed Hyg 2010; 82:801-7.